Orion publishes Interim Report for January–March 2025 and holds a webcast on 23 April 2025
ORION CORPORATION PRESS RELEASE 9 APRIL 2025 at 13.30 EEST Orion publishes Interim Report for January–March 2025 and holds...
Pharmaceutical
Barbara Weber, M.D., Elected to ITM Supervisory Board
Barbara Weber, M.D., Elected to ITM Supervisory Board Headshot Barbara Weber, M.D. Garching / Munich, Germany, April 09, 2025 –...
ENA Respiratory Partners with University of Maryland and Leading Respiratory Disease Expert to Conduct Phase 2 Study of INNA-051 Antiviral Host Defence Enhancer
Phase 2 to evaluate safety, tolerability and efficacy of INNA-051 in the prevention of illness due to viral respiratory infectionsStudy...
Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer
New CCO Joins as Cytosurge Engages in Key Scientific Events Across the USA and BeyondZURICH, Switzerland, April 09, 2025 (GLOBE...
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025New Clinical Data from Phase 2 Extension Period...
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors
New Chair brings more than three decades of life sciences industry experience, with a successful track record as a biotech...
The effect of aprocitentan for reducing blood pressure and proteinuria in Black patients with resistant hypertension published in Hypertension
Aprocitentan, on top of background therapy, showed clinically meaningful and durable blood pressure (BP) reduction and a decrease in proteinuria...
US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirement
Allschwil, Switzerland – April 9, 2025Idorsia Ltd (SIX: IDIA) today announced that the US Food & Drug Administration (FDA), after...
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company...
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort
-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in third cohort, permitting escalation in next dose concentrationMarlborough, Massachusetts--(Newsfile...
Major Cost Savings on Top Cancer Drugs with India-Approved Alternatives
Patients Can Save Thousands on Life-Saving Oncology Medications by Accessing Safe, Affordable Options says SaveRxCanada.to VANCOUVER, BC, April 9, 2025...
INSTITUTE FOR SUPPLY MANAGEMENT® HONORS 30 UNDER 30 RISING SUPPLY CHAIN STARS
Winners represent future leaders, as standout and passionate problem-solvers TEMPE, Ariz., April 8, 2025 /PRNewswire/ -- The Institute for Supply Management®...
New Report Reveals Point of Care Marketing Spend Surges 171% as Healthcare Marketing Landscape Transforms
NEW YORK, April 8, 2025 /PRNewswire/ -- A new report from the Point of Care Marketing Association (POCMA) reveals Point...
Healthcare Brands to Gain Enhanced Engagement through CMI Media Group and Compas Collaboration with Microsoft Advertising
PHILADELPHIA, April 8, 2025 /PRNewswire/ -- CMI Media Group, WPP's healthcare specialty agency (NYSE: WPP) and Compas will be working with...
Postbiotics Market to Reach $32.73 Million by 2032, Growing at a CAGR of 10.4% from 2025–Exclusive Report by Meticulous Research®
Market Growth Driven by Growing Awareness of Gut Health and Increasing Demand for Functional Food & Beverages REDDING, Calif., April...
Reimagining Inclusive Healthcare Marketing: Culture+ Group Launches Specialty Business Unit, CIEN+ Health, Introducing Novel Impact Healthonomics™ Model
This approach unlocks $1T+ in impact while adapting to shifting demographics in a rapidly evolving healthcare ecosystem. With the launch,...
PhaseV to Present Transformative Use of AI for Clinical Development at Upcoming Events
Presentations to Highlight the Power of Advanced Machine Learning for Enhancing Trial Design, Execution and Analysis BOSTON, April 8, 2025...
ProofPilot Chief Strategy Officer Joseph Kim Joins Leadership Council of the Society for Clinical Research Sites
NEW YORK, April 8, 2025 /PRNewswire/ -- ProofPilot, the leading end-to-end Clinical Experience Platform (CXP), is proud to announce that its...
Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research
Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech...